SecBot SecBot
13FINSTITUTION · CIK 0001346824 · 2026-Q2 · Filed Aug 14, 2026

Ra Capital Management

RA CAPITAL MANAGEMENT, L.P.
$11.5B
13F long value · 2026-Q2
Positions84
CategoryAsset manager
Quarters tracked9
●#437 of 556 by 13F long value
Size rank 3/10
14NEW5ADD4TRIM16EXIT
Snapshot
Ra Capital Management's 13F portfolio at a glance: size, concentration and this quarter's activity.
13F long value
$11.5B
Positions
84 (1 unmapped)
Top 84 long weight
100.0%
Quarters tracked
9
Latest 13F filed
Aug 14, 2026
New positions
14
Exits / near-exits
16
13F long value by quarter
Reported long equity value each quarter: fund flows plus market moves. Option notional is not included.
$7.6B
2024-Q2
$8.7B
2024-Q3
$7.5B
2024-Q4
$6.0B
2025-Q1
$5.9B
2025-Q2
$8.1B
2025-Q3
$9.8B
2025-Q4
$9.4B
2026-Q1
$11.5B
2026-Q2
Top holdings · 2026-Q2
The fund's largest reported positions.
TickerIssuerWeightValueSharesSince 2026-Q2
ASND Ascendis Pharma A/SAscendis Pharma A/S23.8%$2.7B10.3M+1.9%
PBLS Parabilis Medicines, Inc.Parabilis Medicines, Inc.6.9%$791.9M28.9M+3.9%
RYTM RHYTHM PHARMACEUTICALS, INC.RHYTHM PHARMACEUTICALS, INC.6.4%$740.2M6.7M-3.2%
PCVX Vaxcyte, Inc.Vaxcyte, Inc.5.8%$667.0M11.5M+6.0%
SION Sionna Therapeutics, Inc.Sionna Therapeutics, Inc.3.8%$435.7M9.9M-92.9%
TYRA Tyra Biosciences, Inc.Tyra Biosciences, Inc.3.4%$389.6M12.2M-38.2%
EWTX Edgewise Therapeutics, Inc.Edgewise Therapeutics, Inc.3.0%$341.0M8.4M+7.5%
NAMS NewAmsterdam Pharma Co N.V.NewAmsterdam Pharma Co N.V.2.8%$323.7M9.6M-42.6%
COAG Hemab Therapeutics Holdings, Inc.Hemab Therapeutics Holdings, Inc.2.5%$286.8M7.8M+6.3%
SEPN Septerna, Inc.Septerna, Inc.2.0%$234.3M7.0M+24.4%
BCAX Bicara Therapeutics Inc.Bicara Therapeutics Inc.1.9%$215.4M7.3M-67.2%
MLYS Mineralys Therapeutics, Inc.Mineralys Therapeutics, Inc.1.8%$207.6M7.7M-46.1%
GHRS GH Research PLCGH Research PLC1.8%$205.3M7.6M-30.2%
IRON Disc Medicine, Inc.Disc Medicine, Inc.1.6%$179.2M2.5M+4.7%
SGP SpyGlass Pharma, Inc.SpyGlass Pharma, Inc.1.6%$178.6M8.0M+44.8%
Quarterly changes · 2026-Q2
What Ra Capital Management opened, added, trimmed and exited this quarter, largest dollar moves first.
ActionTickerIssuerPrev sharesCurr sharesChangeValue Δ
NEWPBLS NEW Parabilis Medicines, Inc. Parabilis Medicines, Inc.028.9MNew+$791.9M
NEWCOAG NEW Hemab Therapeutics Holdings, Inc. Hemab Therapeutics Holdings, Inc.07.8MNew+$286.8M
EXITDNTH EXIT Dianthus Therapeutics, Inc. /DE/ Dianthus Therapeutics, Inc. /DE/2.6M0-100.0%-$219.2M
NEWABVX NEW Abivax S.A. Abivax S.A.01.1MNew+$150.9M
NEWORKA NEW Oruka Therapeutics, Inc. Oruka Therapeutics, Inc.01.6MNew+$148.0M
EXITPRAX EXIT Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc.373.8K0-100.0%-$120.4M
ADDARTV ADD Artiva Biotherapeutics, Inc. Artiva Biotherapeutics, Inc.9.9M18.0M+82.2%+$110.7M
TRIMNUVL TRIM Nuvalent, Inc. Nuvalent, Inc.2.5M1.2M-50.8%-$105.7M
EXITSRPT EXIT Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc.3.9M0-100.0%-$84.9M
EXITSYRE EXIT Spyre Therapeutics, Inc. Spyre Therapeutics, Inc.1.6M0-100.0%-$81.8M
Conviction over time
Portfolio weight of the current top long holdings, quarter by quarter; rising weight = growing conviction.
ASND No history 23.8%
PBLS No history 6.9%
RYTM 6.4%
PCVX 5.8%
SION 3.8%
TYRA 3.4%
EWTX 3.0%
NAMS 2.8%
COAG No history 2.5%
SEPN 2.0%